Unilateral Neuralgiform Headache (SUNCT/SUNA)

“Unilateral neuralgiform headache” is a group name for very short, very sharp, one-sided head pain attacks. The pain is strictly on one side of the head or face. The pain sits in the areas served by the trigeminal nerve, which includes the eye, the eyebrow, the temple, and the cheek. Each attack lasts seconds to a couple of minutes. Attacks can come once a day or many times a day. The attacks are often paired with “cranial autonomic” signs on the same side of the face. These signs include a red eye, tearing, a stuffy or runny nose, a puffy eyelid, facial sweating, or flushing. Doctors place these headaches in a family called “trigeminal autonomic cephalalgias.” The short-lasting neuralgiform group includes two named patterns called SUNCT and SUNA. The official diagnostic descriptions come from the International Classification of Headache Disorders, Third Edition (ICHD-3). ICHD-3+2ICHD-3+2

A unilateral neuralgiform headache is a very short, very sharp face or head pain that always happens on one side (unilateral) and comes in bursts (seconds to a few minutes). Each burst can be stabbing, electric, or burning, and it often loops in clusters of many attacks per day. Because the same nerve pathways are involved, you may also see automatic body reactions on that side—like a red, watery eye, a sweaty or flushed face, a runny or blocked nostril, or a droopy eyelid. Doctors group these headaches under the “trigeminal autonomic cephalalgias (TACs).” Two main subtypes are:

• SUNCT: Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection (eye redness) and Tearing.

• SUNA: Short-lasting unilateral neuralgiform headache attacks with cranial Autonomic symptoms (you may have redness or tearing, but not necessarily both).

Attacks are brief, so “rescue” painkillers rarely act fast enough. Prevention and trigger control are the heart of treatment. A small number of people have a structural cause (e.g., a blood vessel pressing the trigeminal nerve, pituitary or posterior fossa lesions, or multiple sclerosis). That’s why high-quality brain MRI is important at least once.

Scientists think these attacks involve a reflex loop between the trigeminal pain system and a brainstem autonomic system. Brain scans during attacks show activation near the posterior hypothalamus, which is a small deep brain region that helps regulate autonomic responses. Some patients also show neurovascular contact at the trigeminal nerve root, which means a small artery touches and irritates the nerve. These findings explain why the pain is brief, sharp, and strictly one-sided, and why eye and nose symptoms appear with the pain. ScienceDirectOxford Academic

Doctors always consider whether this headache is primary (no structural cause seen) or secondary (caused by another problem). Even when the pattern fits a primary form, guidelines advise imaging of the brain with dedicated views and basic blood tests when this diagnosis is suspected. This is because a small number of patients have a treatable underlying lesion, especially in the pituitary region or the back of the skull base (posterior fossa). NCBI

---

Types

1) SUNCT
SUNCT stands for “short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing.” In this type, the affected eye becomes red and watery on the same side as the pain. The attacks last 1 to 600 seconds. The pain is moderate to severe. The attacks occur at least once per day when the condition is active. ICHD-3

2) SUNA
SUNA stands for “short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms.” In this type, the patient has one or more cranial autonomic symptoms, but may have only one or neither of the two eye signs (redness and tearing). The pain pattern and duration are like SUNCT. ICHD-3

3) Episodic forms
Episodic SUNCT and episodic SUNA happen in “bouts.” A bout lasts from 7 days to one year and is separated by pain-free periods that last at least 3 months. ICHD-3+1

4) Chronic forms
Chronic SUNCT and chronic SUNA continue for more than one year without a remission, or with remissions shorter than 3 months. ICHD-3+1

These four patterns sit under the ICHD-3 section for short-lasting unilateral neuralgiform headache attacks. The ICHD-3 also clarifies that overlaps and mimics can occur, so careful clinical work is needed. ICHD-3+1

---

Causes

Most people with unilateral neuralgiform headache have no visible structural cause, and the condition is called “primary.” A smaller number have secondary causes. Secondary causes usually sit near the trigeminal nerve root in the pons or at the skull base, or in the pituitary region. Below are 20 causes that clinicians consider. I describe each one in plain terms.

1) Primary (idiopathic) SUNCT/SUNA
In many people, no lesion is found. The brain circuits misfire without a structural problem. The pattern is still real, and it follows the ICHD-3 rules for diagnosis. ICHD-3

2) Trigeminal neurovascular contact
A small artery can touch the trigeminal nerve where it enters the brainstem. The contact can irritate the nerve and trigger brief electric-shock pain waves. This contact has been documented in SUNCT and SUNA using high-resolution MRI. Oxford Academic

3) Pituitary adenoma
A benign tumor of the pituitary gland can press on nearby pain pathways or disturb hormones. This has been reported as a secondary cause of SUNCT/SUNA. Treating the tumor can improve the headache. JCN

4) Other pituitary-region lesions
Not only classic adenomas but also other sellar or parasellar lesions can be linked to these headaches, because of proximity to key pathways. Evaluation adds pituitary hormone tests and targeted MRI views. NCBI

5) Cerebellopontine angle epidermoid tumor
An epidermoid (a slow-growing benign tumor) near the cerebellopontine angle can compress the trigeminal nerve and provoke SUNCT-like attacks. Successful surgery can resolve the pain. JCN

6) Vestibular schwannoma (acoustic neuroma)
A benign nerve sheath tumor at the same angle can touch the trigeminal nerve. This can trigger neuralgiform pain in rare cases. JCN

7) Meningioma at the skull base
A meningioma near Meckel’s cave, the cavernous sinus, or the posterior fossa can irritate trigeminal pathways and cause short, sharp one-sided attacks. JCN

8) Brainstem or posterior fossa vascular malformations
An arteriovenous malformation near the trigeminal root entry zone can disturb the nerve and lead to attacks that look like SUNCT/SUNA. JCN

9) Intracranial aneurysm touching trigeminal pathways
An aneurysm in the posterior circulation can contact the trigeminal root or nearby structures and trigger brief neuralgiform pain spells. JCN

10) Basilar artery dolichoectasia
An enlarged, elongated basilar artery can compress the trigeminal nerve root. This can act like a constant irritant and cause neuralgiform attacks. JCN

11) Multiple sclerosis plaque in the pons
A demyelinating lesion at or near the trigeminal root entry zone can produce SUNCT-like attacks in rare patients. This is a recognized secondary link. ScienceDirect

12) Brainstem ischemic lesion
A small stroke in the lateral pons can injure trigeminal pathways and present with brief, one-sided pain attacks. JCN

13) Post-traumatic trigeminal neuropathy
Head or facial trauma can lead to nerve irritation or scarring that sets off neuralgiform pain. Attack patterns may mimic primary forms. JCN

14) Post-surgical changes around the trigeminal nerve
Operations near the skull base or dental/maxillofacial procedures can occasionally lead to secondary neuralgiform pain due to nerve irritation. JCN

15) Granulomatous inflammation (neurosarcoidosis)
Inflammatory deposits can involve cranial nerves and trigger neuralgiform pain spells on one side. Routine labs and imaging help point to this cause. JCN

16) Brain infections that involve the brainstem
Infections that reach the pons or the trigeminal root can cause secondary neuralgiform pain attacks. This is uncommon but important. JCN

17) Herpes zoster in the trigeminal distribution
Shingles can inflame the trigeminal pathway and create short stabbing pain spells that resemble SUNCT/SUNA. Antiviral treatment addresses the cause. JCN

18) Congenital malformations (for example, Chiari I)
Structural differences at the skull base can alter space or pressure around pain pathways and present with neuralgiform pain in rare cases. JCN

19) Arachnoid cyst near the cerebellopontine angle
A benign fluid-filled cyst in this area can press on the trigeminal nerve and trigger short attacks. JCN

20) Overlap with trigeminal neuralgia due to neurovascular compression
Some patients shift over time between a classic trigeminal neuralgia pattern and a SUNCT/SUNA pattern. Neurovascular compression is often present in these overlap cases. PMCheadachemedicine.com.br

---

Symptoms

These are the features people often report. I list them in simple language. Not every person has all of them. The pattern over time is the key.

1) Pain on one side only.
The pain is “side-locked.” The same side is always involved during an active period.

2) Very short pain attacks.
Each attack lasts seconds to a couple of minutes. Many people describe an “electric” or “stabbing” sensation. ICHD-3

3) Pain around the eye or temple.
The most common location is around the eye, above the eye, or in the temple on the affected side. ICHD-3

4) Attacks happen many times a day.
Some people have a few attacks each day. Others have many attacks in clusters across the day. PMC

5) Red eye on the painful side.
The white of the eye turns red during the attack. This sign is called conjunctival injection. It is very common in SUNCT. ICHD-3

6) Tearing on the same side.
Tears flow from the eye on the painful side during the attack. This is part of the autonomic response. ICHD-3

7) Stuffy or runny nose on the same side.
The nose can block or drip during attacks. This also comes from the autonomic reflex. ICHD-3

8) Swelling of the eyelid.
The upper eyelid can look puffy on the painful side during attacks. ICHD-3

9) Facial sweating or flushing.
The skin on the same side can sweat more or turn red during attacks. ICHD-3

10) A sense of a “saw-tooth” series of stabs.
Some attacks feel like a series of sharp stabs that rise and fall quickly, rather than one single spike. ICHD-3

11) Triggers from touch or movement.
Light touch, talking, chewing, washing the face, or a breeze can trigger attacks in some people. PMC

12) Background sensitivity between attacks.
Some people feel a mild residual ache or tenderness between the very short attacks.

13) Anxiety about the next attack.
Because attacks are sudden and severe, many people feel tense, worried, or on alert between episodes.

14) Sleep disruption in bad periods.
The fear of attacks or late-night clusters can disrupt sleep during active phases.

15) Fixed side by period, with possible long-term side-switch only rarely.
The side stays the same during a bout, but over years the side can switch in a small minority. The pattern of side-locking helps the diagnosis. PMC

---

Diagnostic tests

Doctors diagnose unilateral neuralgiform headache from the story and exam first. Tests aim to confirm the pattern and to rule out secondary causes. Tests also look for signs near the trigeminal nerve, the posterior fossa, and the pituitary region. An MRI of the brain with pituitary views and pituitary blood tests is a recommended baseline work-up because secondary cases can occur. NCBI

A) Physical exam and history

1) Detailed attack history and a simple diary.
You describe how long each attack lasts, how often they come, where they start, and which symptoms accompany them. A diary over days to weeks helps confirm the short duration and high frequency that define this disorder. ICHD-3

2) Mapping the pain and checking it is strictly one-sided.
Your clinician confirms the pain sits in the eye, eyebrow, temple, or cheek on a single side, and that the same side is involved through an active period. ICHD-3

3) Observing cranial autonomic signs during an attack.
Your clinician looks for a red eye, tearing, a puffy eyelid, facial sweating, or a runny nose on the same side during an attack. ICHD-3

4) Trigeminal sensory and corneal reflex checks.
Light touch and pinprick are checked across the three trigeminal divisions. The corneal blink reflex is checked to look for nerve pathway issues if a secondary cause is suspected.

5) Full cranial nerve and visual field exam.
Eye movements, pupils, and visual fields are examined. This helps screen for mass effects near the pituitary and for skull-base causes.

B) Manual or bedside provocation/quantification tests

6) Gentle tactile trigger assessment.
Your clinician may very gently touch the cheek, the upper lip, or the eyebrow with cotton to see if attacks are easily triggered. This is done with care and stopped if it sets off pain.

7) Jaw movement and chewing assessment.
You may be asked to bite, chew, or talk to see if movement triggers attacks. The goal is to document triggers and not to provoke severe pain.

8) Schirmer tear test during an attack.
A small paper strip under the eyelid can measure tear flow and confirm the side-locked tearing that matches the pain side.

9) Simple observation of nasal secretion on the painful side.
The clinician documents whether the nose runs during an attack and whether it is limited to the painful side.

10) Trigger-avoidance trial.
For a few days you avoid known triggers (for example, a strong breeze on the face) to see if attack frequency drops. This is a simple, safe bedside test of real-world triggers.

C) Laboratory and pathological tests

11) Pituitary hormone panel.
Blood tests check prolactin, IGF-1, cortisol/ACTH, TSH, and free T4. These tests screen for pituitary disorders that can mimic or cause SUNCT/SUNA. NCBI

12) Serum prolactin as a focused test.
This test is especially useful if a pituitary adenoma is suspected because prolactin can be high in prolactin-secreting tumors. NCBI

13) ESR and CRP.
These inflammation markers help screen for inflammatory or infectious causes when the story suggests them. JCN

14) Serum ACE.
This test helps screen for sarcoidosis when symptoms or imaging point toward granulomatous disease. JCN

15) Targeted infectious testing.
Tests for varicella-zoster virus (VZV) or other infections are done when the story, exam, or imaging points in that direction. JCN

D) Electrodiagnostic studies

16) Blink reflex study.
This test checks the pathway from the eye to the brainstem and back to the facial nerve. Abnormalities can support a structural issue along the trigeminal-facial circuit in rare secondary cases.

17) Trigeminal somatosensory evoked potentials (SSEPs).
This test can look at conduction along the trigeminal pathway and is rarely used but may support evaluation when imaging is unclear.

E) Imaging tests

18) MRI brain with pituitary protocol and high-resolution trigeminal sequences.
This is the most important imaging test. Thin-slice MRI with dedicated sellar (pituitary) views and 3D T2 sequences (like CISS or FIESTA) can show a pituitary lesion, a posterior fossa tumor, or neurovascular contact at the trigeminal root. NCBIOxford Academic

19) MR angiography or CT angiography.
These vascular studies can show an aneurysm, an arteriovenous malformation, an enlarged basilar artery, or a vessel loop that touches the trigeminal nerve. JCN

20) Focused follow-up imaging guided by the first MRI.
If the first MRI hints at a specific area, directed follow-up scans are done to fully define the lesion and plan treatment. Examples include repeat pituitary imaging after hormone changes or targeted posterior fossa views. JCN

---

Non-pharmacological treatments (therapies & “other”)

For each item you’ll see: what it is → purpose → how it may help (mechanism).

1. Condition education & plan
   What: A clear explanation of your diagnosis, common triggers, and a written plan.
   Purpose: Lowers fear, improves adherence to prevention, and reduces ER visits.
   Mechanism: Understanding reduces stress-related arousal of pain circuits and helps you avoid attack triggers.

2. Trigger diary & avoidance
   What: Note time, activity, foods, weather, and face contact before attacks.
   Purpose: Identify patterns (chewing gum, tooth-brushing, cold wind, talking, touching “trigger zones”).
   Mechanism: Removing mechanical or thermal stimulation lowers trigeminal firing.

3. Face and scalp protection
   What: Soft scarf, mask, or wind-blocking glasses outdoors; avoid cold air blasts.
   Purpose: Reduce cold-wind and air-movement triggers.
   Mechanism: Less temperature/airflow on trigeminal skin fields → fewer reflex discharges.

4. Gentle oral care routine
   What: Use a soft toothbrush, lukewarm water, and slow movements.
   Purpose: Minimize attacks during brushing or flossing.
   Mechanism: Lower mechanical stimulation on oral/facial trigger zones.

5. Chewing and speech strategies
   What: Small bites; choose soft foods during active periods; consider “rest breaks” when speaking a lot.
   Purpose: Reduce chewing/talking-related bursts.
   Mechanism: Less repetitive motion on trigger zones.

6. Regular sleep schedule
   What: Same bedtime/wake time; a dark, quiet bedroom; no screens 60 minutes before bed.
   Purpose: Stabilize brainstem pain-control systems.
   Mechanism: Rested hypothalamic/brainstem circuits dampen trigeminal excitability.

7. Hydration and steady meals
   What: Fluids through the day; don’t skip meals.
   Purpose: Prevents physiologic stress that can lower pain thresholds.
   Mechanism: Stable glucose and fluid status support neuronal stability.

8. Mindfulness-based stress reduction (MBSR)
   What: 10–20 minutes/day guided breathing/body scan.
   Purpose: Lower sympathetic overdrive that can amplify pain.
   Mechanism: Increases prefrontal inhibition of pain networks; reduces limbic amplification.

9. Cognitive behavioral therapy (CBT) for pain
   What: Short program focused on coping, pacing, and catastrophic thought reframing.
   Purpose: Reduce fear–pain cycle and disability.
   Mechanism: Rewires appraisal of sensations and lowers central sensitization.

10. Paced breathing (4-6 breaths/min)
    What: Slow diaphragmatic breathing a few minutes, several times daily.
    Purpose: On-the-spot calming during prodrome or high-risk triggers.
    Mechanism: Vagal activation reduces sympathetic tone and pain facilitation.

11. Progressive muscle relaxation
    What: Tense-release cycles from feet to face.
    Purpose: Calms pericranial muscle tension that can irritate superficial branches.
    Mechanism: Lowers nociceptive input from muscle spindles to trigeminal nuclei.

12. Biofeedback (thermal/HRV)
    What: Feedback-guided training to raise hand temperature or improve heart-rate variability.
    Purpose: Better autonomic balance; fewer attacks in some.
    Mechanism: Conditioning toward parasympathetic dominance dampens triggers.

13. Gentle cervical/upper-thoracic physical therapy
    What: Posture work, mobility, and soft-tissue techniques (no high-velocity thrusts).
    Purpose: Reduce cervicogenic inputs that can converge on trigeminal pathways.
    Mechanism: Decreases nociceptive convergence at the trigeminocervical complex.

14. Workstation ergonomics
    What: Neutral neck posture, screen at eye level, headset for long calls.
    Purpose: Prevents neck strain that can feed trigeminal circuits.
    Mechanism: Less sustained muscle activation → fewer nociceptive signals.

15. Light and glare management
    What: Anti-glare screens, matte lighting, sunshades.
    Purpose: Lower photo-sensory discomfort that can co-trigger attacks.
    Mechanism: Less trigeminal-ocular input.

16. Heat/cool trial for prodrome
    What: Brief, gentle warm or cool packs to the side of pain (wrapped; not extreme).
    Purpose: Some find a “gate” effect on sensory traffic.
    Mechanism: Competing thermal input can inhibit nociceptive transmission.

17. Non-invasive neuromodulation (under clinician guidance)
    What: External trigeminal nerve stimulation (eTNS), non-invasive vagus nerve stimulation (nVNS).
    Purpose: Option when medicines are limited or as add-on.
    Mechanism: Alters excitability of trigeminal/brainstem networks.

18. Nasal hygiene when congested
    What: Saline sprays or gentle rinses if your nose is stuffy (check with clinician).
    Purpose: Reduce intranasal mechanical triggers.
    Mechanism: Calmer nasal mucosa gives fewer trigeminal reflex inputs.

19. Treat comorbid conditions
    What: Manage dental problems, sinus disease, sleep apnea, depression/anxiety.
    Purpose: Remove “background amplifiers” of pain circuits.
    Mechanism: Lowering systemic nociceptive load reduces attack readiness.

20. Support network & pacing
    What: Family/colleague education, workload pacing during flare-ups.
    Purpose: Prevents overexertion and reduces stress spikes.
    Mechanism: Fewer stress surges → fewer attacks.

Important: Non-drug strategies are safe anchors, but they do not replace medical evaluation, imaging when indicated, or preventive medication when needed.

---

Drug treatments

Doses are typical adult ranges and must be individualized by your clinician based on age, kidney/liver function, interactions, pregnancy status, and local guidance.

1. Lamotrigine
   Class: Sodium-channel modulator (antiepileptic).
   Typical dose & timing: Slow titration to 100–400 mg/day divided; start low to prevent rash.
   Purpose: First-line preventive for SUNCT/SUNA to reduce attack frequency and intensity.
   Mechanism: Stabilizes hyper-excitable trigeminal neurons by limiting repetitive firing.
   Key side effects: Dizziness, nausea, insomnia; rare but serious rash (SJS/TEN)—titrate slowly, avoid abrupt changes, extra caution with valproate.

2. Topiramate
   Class: Broad-spectrum antiepileptic (multiple mechanisms).
   Typical dose & timing: 50–200 mg/day divided.
   Purpose: Preventive when lamotrigine is not tolerated or as add-on.
   Mechanism: Enhances GABA, blocks AMPA/kainate receptors, and moderates voltage-gated channels.
   Key side effects: Paresthesias, cognitive slowing, weight loss, kidney stones, glaucoma risk—hydration and monitoring advised.

3. Carbamazepine
   Class: Sodium-channel blocker (antiepileptic).
   Typical dose & timing: 200–800 mg/day divided (sometimes higher with monitoring).
   Purpose: Preventive, especially if attacks feel shock-like with clear trigger zones.
   Mechanism: Limits high-frequency neuronal firing in trigeminal pathways.
   Key side effects: Drowsiness, hyponatremia, liver enzyme changes, rash; drug–drug interactions (CYP inducer); HLA-B*1502 testing in at-risk ancestries.

4. Oxcarbazepine
   Class: Sodium-channel blocker (carbamazepine analog).
   Typical dose & timing: 300–1200 mg/day divided.
   Purpose: Alternative to carbamazepine with fewer interactions.
   Mechanism: Similar neuronal stabilization.
   Key side effects: Hyponatremia, dizziness; fewer hepatic interactions than carbamazepine.

5. Gabapentin
   Class: α2δ calcium-channel modulator.
   Typical dose & timing: 900–3600 mg/day divided.
   Purpose: Add-on preventive in neuropathic-style presentations.
   Mechanism: Reduces excitatory neurotransmitter release.
   Key side effects: Sedation, dizziness, edema; adjust for kidney function.

6. Pregabalin
   Class: α2δ calcium-channel modulator.
   Typical dose & timing: 150–450 mg/day divided.
   Purpose: Alternative to gabapentin with more predictable absorption.
   Mechanism: Similar to gabapentin; may calm hyper-active trigeminal afferents.
   Key side effects: Drowsiness, weight gain, edema; adjust for kidney function.

7. Mexiletine (specialist use)
   Class: Oral sodium-channel blocker (lidocaine analog).
   Typical dose & timing: ~150–600 mg/day divided; specialist supervision only.
   Purpose: For refractory cases responding to IV lidocaine but needing an oral option.
   Mechanism: Dampens ectopic neuronal firing.
   Key side effects: GI upset, tremor, arrhythmia risk; ECG monitoring required.

8. Intravenous lidocaine (transitional therapy, inpatient/monitored)
   Class: Sodium-channel blocker.
   Typical dose & timing: Continuous monitored infusion over 1–5 days per protocol.
   Purpose: Rapid short-term suppression during severe clusters while a preventive is titrated.
   Mechanism: Potent membrane stabilization in trigeminal pathways.
   Key side effects: Arrhythmias, CNS symptoms; must be given with cardiac monitoring.

9. Phenytoin (acute/rescue; specialist)
   Class: Sodium-channel blocker.
   Typical dose & timing: IV loading per protocol in monitored settings.
   Purpose: Occasionally used for explosive exacerbations.
   Mechanism: Limits high-frequency discharges.
   Key side effects: Hypotension, arrhythmias (IV), rash, ataxia; monitoring essential.

10. Valproate (select cases; consider risks)
    Class: Broad antiepileptic/mood stabilizer.
    Typical dose & timing: 500–1500 mg/day divided.
    Purpose: Preventive add-on if others fail.
    Mechanism: GABAergic enhancement and membrane stabilization.
    Key side effects: Weight gain, tremor, liver enzyme elevation; contraindicated in pregnancy due to teratogenicity—strict contraception/pregnancy planning required.

Notes:
• Indomethacin is typically ineffective in SUNCT/SUNA; a negative trial can help distinguish from indomethacin-responsive TACs (e.g., paroxysmal hemicrania).
• Short steroid tapers may be tried case-by-case but rarely give sustained control.
• Medication choices are individualized; combinations are common; careful titration and monitoring maximize benefit and safety.

---

Dietary “molecular” supplements

Evidence for SUNCT/SUNA is limited; most data come from headache or neuropathic-pain research. Always discuss with your clinician—supplements can interact with medicines.

1. Magnesium (citrate or glycinate)
   Dose: 200–400 mg elemental/day.
   Function: Neuromodulator; supports normal nerve signaling.
   Mechanism: NMDA receptor modulation may reduce central sensitization.

2. Riboflavin (Vitamin B2)
   Dose: 200–400 mg/day with food.
   Function: Mitochondrial cofactor; headache prevention signal in migraine literature.
   Mechanism: Improves cellular energy handling in neurons.

3. Coenzyme Q10
   Dose: 100–300 mg/day.
   Function: Mitochondrial antioxidant; may support neuronal energy.
   Mechanism: Reduces oxidative stress that can lower firing thresholds.

4. Omega-3 fatty acids (EPA/DHA)
   Dose: 1–2 g combined EPA/DHA/day.
   Function: Anti-inflammatory milieu.
   Mechanism: Resolvin pathways may dampen neuroinflammation.

5. Vitamin D3
   Dose: 1000–2000 IU/day (or per level-guided plan).
   Function: Immune and neuromuscular support.
   Mechanism: Modulates inflammatory signaling; corrects deficiency.

6. Melatonin
   Dose: 2–5 mg 1–2 hours before bedtime.
   Function: Sleep regularization; has headache-modulating properties.
   Mechanism: Acts on hypothalamic and pain circuits; circadian stabilization.

7. Alpha-lipoic acid
   Dose: 300–600 mg/day.
   Function: Antioxidant used in neuropathic pain.
   Mechanism: Lowers oxidative stress and may improve nerve function.

8. Curcumin (with piperine or enhanced formulation)
   Dose: 500–1000 mg/day standardized extract.
   Function: Anti-inflammatory adjunct.
   Mechanism: NF-κB pathway modulation; microglial calming (preclinical/adjunctive evidence).

9. Palmitoylethanolamide (PEA)
   Dose: 600–1200 mg/day.
   Function: Endogenous fatty-acid amide with analgesic/anti-inflammatory signals.
   Mechanism: PPAR-α activation; mast-cell/microglia modulation.

10. Feverfew (caution; quality matters)
    Dose: 50–150 mg/day standardized to parthenolide.
    Function: Traditional headache herb; mixed data.
    Mechanism: Possible prostaglandin and serotonin pathway effects.
    Safety note: GI upset possible; avoid if allergic to ragweed; discuss if pregnant.
    (Butterbur is not recommended due to liver toxicity risk unless certified PA-free and supervised.)

---

Regenerative / stem-cell” drugs — what you should know

There are no proven, approved “immunity booster,” regenerative, or stem-cell drugs for unilateral neuralgiform headaches. Offering dosages for such products would be misleading and unsafe. Below are six commonly marketed ideas and why they are not recommended:

1. IV stem-cell infusions (various sources)
   No established dose, no evidence of benefit in SUNCT/SUNA, potential for infection/immune reactions. Avoid outside clinical trials.

2. Exosome therapies
   Unregulated; product variability; no controlled data for TACs; theoretical risks.

3. Platelet-rich plasma (PRP) perineural injections
   Evidence is for tendons/joints, not trigeminal autonomic headaches; nerve injury risk.

4. High-dose IV “immune cocktails” (vitamins/ozone/peroxide)
   No proof for SUNCT/SUNA; can cause vein injury, hemolysis, or oxidative harm.

5. Thymic peptides or unapproved “immune boosters”
   Insufficient evidence; may alter immune function unpredictably; interaction risks.

6. Unregulated “stem-cell pills/drops” sold online
   Marketing claims only; not biologically plausible; risk of contamination and fraud.

Safer, evidence-aligned alternatives: proper preventive medicines, non-invasive neuromodulation, addressing triggers, sleep, nutrition, exercise within your limits, and treating any structural cause if found on imaging.

---

Procedures/surgeries

1. Microvascular decompression (MVD) of the trigeminal nerve
   What it is: Neurosurgeon places a soft pad between a pulsating blood vessel and the trigeminal nerve root (if high-resolution MRI shows neurovascular contact that matches your symptoms).
   Why done: In some refractory SUNCT/SUNA patients, compressing vessels appear to drive attacks.
   Mechanism: Removes mechanical/pulsatile irritation, reducing ectopic discharges.
   Risks: Hearing changes, facial numbness, CSF leak, stroke (rare), infection. Reserved for carefully selected patients.

2. Occipital nerve stimulation (ONS)
   What it is: Implanted leads under the skin over the occipital nerves connect to a pulse generator.
   Why done: When medications fail and attacks are disabling.
   Mechanism: Neuromodulates the trigeminocervical complex to reduce attack frequency/intensity.
   Risks: Lead migration, infection, battery changes; requires experienced centers.

3. Sphenopalatine ganglion (SPG) stimulation (implantable)
   What it is: Small stimulator near the SPG (deep in face) activated by a handheld device during attacks.
   Why done: In TACs, SPG modulation can blunt attacks; evidence in SUNCT/SUNA is emerging for refractory cases.
   Risks: Surgical site pain, sensory changes, device issues.

4. Percutaneous radiofrequency ablation (RFA) of the SPG or trigeminal branches
   What it is: Needle-guided heat lesion to dampen hyperactive pain pathways.
   Why done: To reduce attack frequency when other options fail.
   Mechanism: Interrupts aberrant nociceptive signaling.
   Risks: Numbness, dysesthesia, bleeding, infection; pain can recur.

5. Treat the underlying lesion (if secondary cause is found)
   What it is: Focused surgery or targeted therapy (e.g., pituitary adenoma resection, sinus or posterior fossa lesion management).
   Why done: When imaging reveals a structural driver of the headache.
   Mechanism: Removing the cause removes the trigger; can be curative.
   Risks: Specific to the lesion and procedure; managed by the appropriate specialty team.

Note: Nerve blocks (e.g., greater occipital or SPG with local anesthetic ± steroid) are procedures rather than surgeries and can serve as bridging or diagnostic tools under specialist care.

---

Prevention habits you can start today

1. Keep a regular sleep–wake schedule.

2. Hydrate and avoid skipping meals.

3. Protect your face from cold wind/air blasts.

4. Use a soft toothbrush and gentle chewing strategies.

5. Log triggers and plan around them.

6. Maintain neck/shoulder posture; take micro-breaks.

7. Practice daily relaxation (mindfulness or breathing).

8. Treat comorbidities (dental, sinus, mood, sleep apnea).

9. Consider non-invasive neuromodulation if advised.

10. Follow-up regularly to fine-tune preventives and catch medication side effects early.

---

When to see a doctor (or go now)

• New one-sided, stabbing head/face pain with eye redness/tearing, especially with many daily attacks.

• A change in your usual pattern (more intense, longer, new symptoms).

• Neurological signs: double vision, weakness, numbness, slurred speech, severe imbalance.

• Fever, stiff neck, severe eye pain, or vision changes.

• After head trauma or if you are pregnant or planning pregnancy.

• Age >50 with new head pain.

• Immunocompromised status or cancer history.

• Any time pain is so frequent or severe that daily function or sleep is unsafe.

---

What to eat and what to avoid

What to eat”

1. Regular meals with complex carbs (oats, brown rice) to keep blood sugar steady.

2. Magnesium-rich foods: leafy greens, beans, nuts, seeds.

3. Omega-3 sources: fatty fish (salmon, sardines), flax, walnuts.

4. Lean proteins: eggs, tofu, poultry, lentils—easier chewing options help.

5. Hydrating foods: cucumbers, citrus, soups.

6. B-vitamin foods: dairy/yogurt, mushrooms, fortified cereals.

7. Colorful vegetables (antioxidants): peppers, carrots, berries.

8. Turmeric/ginger in cooking (gentle anti-inflammatory support).

9. Probiotic foods: yogurt with live cultures, kefir, fermented vegetables—if tolerated.

10. Sleep-friendly snacks in the evening: a small banana, warm milk, or tart-cherry products.

What to avoid or limit”

1. Skipping meals or strict fasting.

2. Very cold foods/drinks if they trigger attacks.

3. Very chewy/hard foods during active periods (bagels, tough meats).

4. Excess caffeine (withdrawal or overuse can both unsettle headaches).

5. High-nitrite processed meats if you notice sensitivity.

6. Monosodium glutamate (MSG) or ultra-processed foods—monitor your own response.

7. Alcohol if it personally triggers you (not universal in SUNCT/SUNA, but some are sensitive).

8. Artificial sweeteners (e.g., aspartame) if you notice a link.

9. Strong spices or very hot foods if they set off oral/nasal trigger zones.

10. Dehydration—carry a water bottle.

---

FAQs

1) Is unilateral neuralgiform headache the same as trigeminal neuralgia?
No. Both are one-sided and can be “electric,” but SUNCT/SUNA attacks are usually shorter, more frequent, and have autonomic signs (red watery eye, runny nose). Trigeminal neuralgia typically lacks those eye/nose features.

2) How long do attacks last?
Usually seconds to a few minutes, sometimes repeating in waves dozens of times per day.

3) What’s the difference between SUNCT and SUNA?
SUNCT requires both eye redness and tearing during attacks. SUNA requires at least one autonomic sign (e.g., redness or tearing or nasal symptoms), but not necessarily both.

4) Do common painkillers help?
Not usually. Attacks are too brief for standard pills to act in time. Prevention is the main strategy.

5) Which preventive medicine is first-line?
Lamotrigine is commonly used first, followed by topiramate or sodium-channel blockers (carbamazepine/oxcarbazepine). Your doctor chooses based on your history and risks.

6) Will this damage my brain?
The pain is severe but typically does not cause brain damage. However, missing a structural cause is risky—get proper imaging once.

7) Do I really need an MRI?
Most specialists recommend at least one high-quality MRI of the brain (often with trigeminal/pituitary views) to rule out structural causes, especially if your story is atypical.

8) Could dental or sinus problems be the cause?
Sometimes local issues can mimic or aggravate symptoms. Dental and ENT assessments are reasonable if red flags or local symptoms exist.

9) Is this hereditary?
Clear hereditary patterns are uncommon. Family history can exist but is not typical.

10) Can I drive during attacks?
If attacks are frequent/unpredictable, avoid driving until your plan controls them. Safety first.

11) Is pregnancy compatible with treatment?
Yes, but medication choices change. Tell your clinician early for a safer plan (some medicines—like valproate—are avoided).

12) What if medicines fail?
Confirm the diagnosis, optimize doses, consider add-on therapies, non-invasive neuromodulation, nerve blocks, and—in highly selected cases—implanted neuromodulation or MVD if imaging supports it.

13) Are Botox injections helpful?
Botulinum toxin has strong evidence in chronic migraine; evidence in SUNCT/SUNA is limited. It may be tried case-by-case when standard options fail.

14) Will it ever go away?
Some people have long remissions; others have chronic patterns. The goal is fewer, weaker, shorter attacks and a fuller life.

15) Which specialist should I see?
A neurologist with headache/TAC expertise. Complex or refractory cases may be co-managed with neurosurgery or pain specialists.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 26, 2025.